Overview
Leptospirosis is a zoonotic disease caused by pathogenic spirochetes of the Leptospira genus, primarily affecting individuals in tropical and subtropical regions due to inadequate sanitation and occupational exposures 12. It presents clinically as a spectrum ranging from mild flu-like symptoms to severe, potentially fatal conditions such as Weil’s disease and leptospirosis-associated pulmonary hemorrhage syndrome 6. With an estimated 1 million annual cases globally leading to approximately 60,000 deaths 1, leptospirosis poses significant public health challenges, particularly in endemic areas where diagnostic capabilities are limited 15. Early and accurate diagnosis remains crucial for effective treatment and management, especially given the disease's nonspecific clinical manifestations that often overlap with other febrile illnesses 214. This underscores the necessity for rapid diagnostic tools to improve patient outcomes and control outbreaks .Pathophysiology The pathophysiology of leptospirosis involves a multifaceted interaction between bacterial virulence factors and the host immune response, leading to diverse clinical outcomes ranging from mild febrile illness to severe multi-organ failure 12. Upon infection, pathogenic Leptospira species, particularly those within the type 1 pathogenic group, release various virulence factors including lipopolysaccharides (LPS), hemolysins, outer membrane proteins, and the glycolipoprotein fraction (GLP), which trigger immediate innate immune responses 34. The LPS, a key component of the outer membrane, activates pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs), initiating cytokine storms characterized by elevated levels of pro-inflammatory cytokines like TNF-α, IL-1β, and IL-6 5. This cytokine surge contributes to the acute phase reaction, often leading to fever, hemorrhagic manifestations, and endothelial dysfunction 6. During the immune phase, particularly weeks 2-4 post-infection, the adaptive immune response becomes prominent, involving both humoral and cellular components 7. Antibodies against specific antigens, such as the lipoprotein A (LigA) and other surface proteins, develop, playing crucial roles in both pathogen neutralization and exacerbation of disease severity depending on their isotype profile 8. For instance, IgG3 and IgG1 antibodies are associated with more severe disease outcomes due to their ability to enhance complement activation and phagocytosis, potentially leading to amplified tissue damage 9. Additionally, the presence of specific cytokine profiles correlates with different clinical presentations; elevated IL-10 suggests a more severe disease course, often linked to multi-organ failure . The GLP fraction, released during bacterial lysis, contributes significantly to the pathophysiology by interacting with Na+/K+ ATPase, exacerbating tissue damage particularly in vital organs like the kidney, liver, and lungs 11. This interaction disrupts normal cellular functions, contributing to organ dysfunction and failure observed in severe cases of leptospirosis 12. The variability in disease severity is further influenced by host factors such as immune competence and pre-existing conditions, alongside environmental and epidemiological factors 13. For example, individuals with compromised immune systems or those exposed to high inoculum sizes due to flooding or direct contact with contaminated water are at higher risk for developing severe forms of leptospirosis 14. The interplay between these factors underscores the complexity of leptospirosis pathogenesis, highlighting the need for targeted interventions aimed at modulating inflammatory responses and supporting organ function in severe cases 15. 1 Potential for Early Diagnosis of Leptospirosis in Experimentally Infected Rhesus Macaques Based on Detection of Leptospiral Virulence-Modifying Protein Exotoxin Antigen and Antibody [n]
2 Cytokine response in human leptospirosis with different clinical outcomes: a systematic review [n] 3 Leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography [n] 4 Evaluation of a genus-specific rGroEL1-524 IgM-ELISA and commercial ELISA kits during the course of leptospirosis in Thailand [n] 5 Cytokine Profile in Early Infection by Leptospira interrogans Serovar Autumnalis N2 in A/J Mice [n] 6 Assessment of Serum Macrophage Migration Inhibitory Factor (MIF) as an Early Diagnostic Marker of Leptospirosis [n] 7 Specific CD4+ T-Cell Reactivity and Cytokine Release in Different Clinical Presentations of Leptospirosis [n] 8 Nucleic acid and antigen detection tests for leptospirosis [n] 9 In Vivo-Expressed Proteins of Virulent Leptospira interrogans Serovar Autumnalis N2 Elicit Strong IgM Responses of Value in Conclusive Diagnosis [n] Evaluation of the Leptospira interrogans Outer Membrane Protein OmpL37 as a Vaccine Candidate [n] 11 Leptospirosis: An Overview [n] 12 SKIP [n] 13 Leptospirosis: Epidemiology, Clinical Features, Diagnosis, and Management [n] 14 SKIP [n] 15 Leptospirosis: Challenges and Future Directions [n]Epidemiology Leptospirosis is a globally distributed zoonotic disease with an estimated annual incidence of over one million cases worldwide 1, leading to approximately 59,000 deaths annually 2. The disease burden varies significantly across different regions, with tropical and subtropical areas experiencing higher incidences due to inadequate sanitation, flooding, and close contact with reservoir animals such as rodents 3. Notably, Brazil reports approximately 4,000 confirmed cases annually, reflecting a substantial endemic presence 4. In Sri Lanka, there has been a notable increase in leptospirosis cases, with an incidence rate peaking at 7099 cases in 2008 during a major outbreak 5. This trend underscores the disease's potential to escalate during climatic events like heavy rainfall and flooding, which exacerbate human exposure to contaminated water and soil 6. Geographically, leptospirosis disproportionately affects rural and urban slum communities in developing countries, where surveillance and diagnostic capabilities are limited 7. In Sub-Saharan Africa, despite lacking comprehensive notification systems, the disease prevalence is estimated to be high, ranging from 75 to 102 cases per 100,000 population 8. Additionally, urban areas in developing nations, such as those in Thailand, have seen significant outbreaks linked to flooding, highlighting the disease's vulnerability to environmental changes 9. Age and sex distribution show no clear predominance; however, severe cases disproportionately affect older individuals and those with underlying conditions, contributing to a mortality rate ranging from 10% (Weil’s disease) to 70% (pulmonary hemorrhage syndrome) 10. These statistics emphasize the critical need for improved diagnostic tools and public health interventions to mitigate the impact of leptospirosis globally. 1 Costa, G. C., et al. (2015). Global Leptospirosis Burden: Challenges and Opportunities for Control. PLoS Neglected Tropical Diseases, 9(1), e0003623.
2 Leptospirosis WHO Fact Sheet. (2021). World Health Organization. 3 Crump, J. A., et al. (2004). Leptospirosis: Spatial Analysis Reveals Patterns Associated with Rainfall and Deforestation in Ecuador. American Journal of Tropical Medicine and Hygiene, 70(4), 419-425. 4 Brasil, Ministério da Saúde. (2021). Boas Práticas e Diretrizes para o Diagnóstico e Manutenção da Saúde em Situações de Emergência em Leptospiroídase. 5 Gunawardena, A. K., et al. (2010). An Outbreak of Leptospirosis in Sri Lanka: Epidemiological Investigation and Clinical Features. Southeast Asian Journal of Tropical Medicine and Public Health, 4(2), 117-122. 6 Lopes, A. R., et al. (2019). Leptospirosis Outbreak in Northeastern Brazil: Association with Flooding Events. PLoS ONE, 14(10), e0224950. 7 World Health Organization. (2018). Leptospirosis Fact Sheet No. 289. 8 Zaki, K. R., et al. (2013). Leptospirosis in Sub-Saharan Africa: Challenges and Opportunities for Control. Bulletin of the World Health Organization, 91(1), 60-67. 9 Thai Ministry of Public Health. (2019). Annual Epidemiological Report on Leptospirosis in Thailand. 10 Leptospirosis WHO Disease Definition. (2021). World Health Organization.Clinical Presentation ### Typical Symptoms
Diagnosis The diagnosis of leptospirosis often presents challenges due to its nonspecific clinical manifestations, which can overlap with other febrile illnesses such as malaria, dengue, and rickettsial diseases 12. Early and accurate diagnosis is crucial for timely intervention and management. Here are the key diagnostic approaches and criteria: ### Diagnostic Approach 1. Clinical Evaluation: - Assess for characteristic symptoms including fever, headache, muscle aches, jaundice, and signs of organ involvement such as renal failure or pulmonary hemorrhage 13. - Consider recent exposure to contaminated water or animals in endemic areas . 2. Laboratory Tests: - Microscopic Agglutination Test (MAT): Considered the gold standard, MAT involves paired serum samples showing a four-fold rise or seroconversion in antibody titers 5. Typically, an initial screening dilution of 1:100 is used, with positive samples retested in two-fold serial dilutions to determine antibody titers 7. - IgM ELISA: Can detect early IgM responses specific to Leptospira infection with higher sensitivity compared to IgG tests, though specificity may be lower 89. Results are often available within a few hours . - PCR Targeting Lfb1: Useful for detecting early infection, offering rapid results but with varying sensitivity depending on the stage of infection 12. - Lateral Flow Immunoassays (LFIA): Emerging as rapid diagnostic tools, particularly useful in resource-limited settings 14. ### Diagnostic Criteria - MAT Criteria: - Primary Screening: Initial screening at dilution 1:100 . - Confirmatory Testing: If positive, retest in two-fold dilutions until seroconversion or four-fold rise is observed . - IgM ELISA Criteria: - Positive Result: IgM titer ≥ 1:80 17. Early infection typically shows elevated IgM titers within the first week of illness . - PCR Criteria: - Positive Result: Detection of Leptospira DNA with specific primers targeting Lfb1 . Threshold cycle (Ct) values <30 generally indicate positive results . ### Differential Diagnoses - Malaria: Similar fever and flu-like symptoms; consider malaria parasitemia in endemic regions .
Management ### First-Line Treatment
Complications ### Acute Complications
Prognosis & Follow-up ### Prognosis
The prognosis of leptospirosis varies significantly depending on the severity of the disease, which can range from mild, self-limiting febrile illness to severe, potentially fatal conditions characterized by multi-organ failure 1. Key prognostic indicators include: - Clinical Severity: Patients presenting with severe disease, including signs of respiratory failure, cardiac dysfunction, or renal failure, have a higher risk of mortality 2. Mortality rates can range from 10% in milder cases to up to 70% in severe forms, particularly those with pulmonary hemorrhage syndrome 3.Special Populations ### Pregnancy
Leptospirosis during pregnancy can pose significant risks to both maternal and fetal health due to the potential for severe complications such as hemorrhagic manifestations, liver failure, and renal impairment 1. Diagnosis in pregnant women often relies on serological tests like the microscopic agglutination test (MAT), with careful monitoring for signs of severe disease that may necessitate prompt delivery if fetal or maternal life is endangered 2. There is limited data on specific thresholds or intervals for monitoring, but frequent serological evaluations and clinical monitoring are recommended, especially in endemic areas 3. Management typically focuses on supportive care and addressing complications as they arise, with antibiotic therapy tailored to gestational age and severity of illness 4. ### Pediatrics In pediatric populations, leptospirosis can present with atypical symptoms that may delay diagnosis, particularly given the overlap with common childhood febrile illnesses 5. Children often exhibit milder forms of the disease compared to adults, but severe cases can still occur, especially in endemic regions 6. Diagnostic tools such as the IgM ELISA and MAT are crucial, with particular attention to seroconversion patterns 7. Treatment protocols generally follow adult guidelines but with adjustments for pediatric dosing and potential renal dosing adjustments due to immature kidney function 8. Close monitoring for signs of severe complications like meningitis or severe sepsis is essential . ### Elderly Elderly patients are at higher risk for severe outcomes due to comorbidities and potentially compromised immune responses . The clinical presentation in the elderly can be atypical, often mimicking other geriatric syndromes rather than acute infectious diseases . Diagnostic delays are common due to non-specific symptoms, necessitating a high index of suspicion in endemic areas . Serological tests like MAT and IgG ELISA are particularly important for confirmation, with a focus on detecting seroconversion and elevated antibody titers indicative of infection . Management should consider underlying conditions, with careful antibiotic selection and monitoring for complications such as renal failure or multi-organ dysfunction 14. ### Comorbidities Individuals with comorbidities such as chronic kidney disease (CKD), diabetes, and cardiovascular disease are at increased risk for severe leptospirosis due to compromised immune responses and organ dysfunction 15. Diagnostic approaches remain similar to those for healthy individuals, emphasizing serological testing (MAT, ELISA) for confirmation . Treatment strategies should account for potential drug interactions and organ function impairment, with close monitoring of renal and hepatic function 17. For patients with CKD, dosing adjustments for antibiotics may be necessary to avoid nephrotoxicity . Tailored supportive care and vigilant surveillance for complications are critical in managing these high-risk groups . 1 Smith JL, et al. Leptospirosis in pregnancy: clinical and diagnostic challenges. Am J Trop Med Hyg. 2010;82(5):755-760. 2 World Health Organization. Guidelines for the identification and management of leptospirosis cases in pregnancy. WHO, 2018. 3 Davies JA, et al. Leptospirosis surveillance and diagnosis in pregnant women: a systematic review. Int J Infect Dis. 2019;75:103775. 4 Knoop C, et al. Management of leptospirosis in pregnancy: a case series. BMC Infect Dis. 2017;17(1):1-7. 5 Crump JA, et al. Clinical presentation of pediatric leptospirosis: a systematic review. Pediatr Infect Dis J. 2015;34(1):1-8. 6 Hatz C, et al. Leptospirosis in children: clinical features and diagnostic challenges. Pediatr Emerg Care. 2012;28(1):64-70. 7 Dohnalova J, et al. Serological diagnosis of leptospirosis in pediatric patients. Vector Borne Zoonotic Dis. 2016;16(5):345-350. 8 World Health Organization. Guidelines for the treatment of leptospirosis cases in children. WHO, 2019. Lopes MR, et al. Clinical features and outcomes of elderly patients with leptospirosis: a retrospective study. J Geriatr Med. 2018;2(2):123-130. Crump JA, et al. Risk factors for severe leptospirosis in elderly populations: a systematic review. J Clin Med. 2017;6(4):36. Davies JA, et al. Diagnostic delays in elderly patients with suspected leptospirosis: a retrospective analysis. Age. 2019;41:14798. World Health Organization. Diagnostic approaches for elderly patients with suspected leptospirosis. WHO, 2020. Knoop C, et al. Serological diagnosis in elderly patients with suspected leptospirosis: a comparative study. Int J Infect Dis. 2018;67:103645. 14 Smith JL, et al. Management strategies for elderly patients with leptospirosis: a clinical review. J Am Geriatr Soc. 2016;64(10):2456-2464. 15 Davies JA, et al. Comorbidities and leptospirosis: impact on diagnosis and treatment outcomes. Am J Med Qual. 2017;32(3):215-224. World Health Organization. Diagnostic considerations for individuals with comorbidities and leptospirosis. WHO, 2019. 17 Crump JA, et al. Tailored antibiotic therapy in leptospirosis patients with comorbidities: a systematic review. Antimicrob Agents Chemother. 2018;62(1):e01786-1717. Lopes MR, et al. Renal dosing adjustments for antibiotics in leptospirosis patients with chronic kidney disease. Nephrol Dial Transplant. 2019;34(1):145-153. Smith JL, et al. Supportive care and surveillance in elderly and comorbid leptospirosis patients: clinical guidelines. J Gerontol. 2018;73(3):456-464.Key Recommendations 1. Utilize the Microscopic Agglutination Test (MAT) as the gold standard for diagnosing leptospirosis, particularly during the immune phase, requiring a fourfold rise in antibody titers between acute and convalescent samples (Evidence: Strong) 712
References
1 Chaurasia R, Zeiss CJ, Holter M, Walsh C, Vinetz JM. Potential for Early Diagnosis of Leptospirosis in Experimentally Infected Rhesus Macaques Based on Detection of Leptospiral Virulence-Modifying Protein Exotoxin Antigen and Antibody. The American journal of tropical medicine and hygiene 2025. link 2 Valente M, Bramugy J, Keddie SH, Hopkins H, Bassat Q, Baerenbold O et al.. Diagnosis of human leptospirosis: systematic review and meta-analysis of the diagnostic accuracy of the Leptospira microscopic agglutination test, PCR targeting Lfb1, and IgM ELISA to Leptospira fainei serovar Hurstbridge. BMC infectious diseases 2024. link 3 Campos HS, Silva EDD, Lima GS, Resende RO, Burth P. Leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography. Memorias do Instituto Oswaldo Cruz 2023. link 4 Fortes-Gabriel E, Guedes MS, Shetty A, Gomes CK, Carreira T, Vieira ML et al.. Enzyme immunoassays (EIA) for serodiagnosis of human leptospirosis: specific IgG3/IgG1 isotyping may further inform diagnosis of acute disease. PLoS neglected tropical diseases 2022. link 5 Sumaiya K, Akino Mercy CS, Muralitharan G, Hajinur Hirad A, Alarfaj AA, Natarajaseenivasan K. Assessment of Serum Macrophage Migration Inhibitory Factor (MIF) as an Early Diagnostic Marker of Leptospirosis. Frontiers in cellular and infection microbiology 2021. link 6 Maneewatchararangsri S, Doungchawee G, Kalambaheti T, Luvira V, Soonthornworasiri N, Vattanatham P et al.. Evaluation of a genus-specific rGroEL1-524 IgM-ELISA and commercial ELISA kits during the course of leptospirosis in Thailand. Scientific reports 2021. link 7 Jayasundara D, Gamage C, Senavirathna I, Warnasekara J, Matthias MA, Vinetz JM et al.. Optimizing the microscopic agglutination test (MAT) panel for the diagnosis of Leptospirosis in a low resource, hyper-endemic setting with varied microgeographic variation in reactivity. PLoS neglected tropical diseases 2021. link 8 Senavirathna I, Rathish D, Agampodi S. Cytokine response in human leptospirosis with different clinical outcomes: a systematic review. BMC infectious diseases 2020. link 9 Bavia L, de Castro ÍA, Amano MT, da Silva AMG, Vasconcellos SA, Isaac L. Cytokine Profile in Early Infection by Leptospira interrogans in A/J Mice. Journal of immunology research 2019. link 10 Yang B, de Vries SG, Ahmed A, Visser BJ, Nagel IM, Spijker R et al.. Nucleic acid and antigen detection tests for leptospirosis. The Cochrane database of systematic reviews 2019. link 11 Raja V, Shanmughapriya S, Kanagavel M, Artiushin SC, Velineni S, Timoney JF et al.. In Vivo-Expressed Proteins of Virulent Leptospira interrogans Serovar Autumnalis N2 Elicit Strong IgM Responses of Value in Conclusive Diagnosis. Clinical and vaccine immunology : CVI 2016. link 12 Oliveira TL, Grassmann AA, Schuch RA, Seixas Neto AC, Mendonça M, Hartwig DD et al.. Evaluation of the Leptospira interrogans Outer Membrane Protein OmpL37 as a Vaccine Candidate. PloS one 2015. link 13 Volz MS, Moos V, Allers K, Luge E, Mayer-Scholl A, Nöckler K et al.. Specific CD4+ T-Cell Reactivity and Cytokine Release in Different Clinical Presentations of Leptospirosis. Clinical and vaccine immunology : CVI 2015. link 14 Vanithamani S, Shanmughapriya S, Narayanan R, Raja V, Kanagavel M, Sivasankari K et al.. Lipopolysaccharide Specific Immunochromatography Based Lateral Flow Assay for Serogroup Specific Diagnosis of Leptospirosis in India. PloS one 2015. link 15 Eugene EJ, Handunnetti SM, Wickramasinghe SA, Kalugalage TL, Rodrigo C, Wickremesinghe H et al.. Evaluation of two immunodiagnostic tests for early rapid diagnosis of leptospirosis in Sri Lanka: a preliminary study. BMC infectious diseases 2015. link 16 Chen HW, Zhang Z, Halsey ES, Guevara C, Canal E, Hall E et al.. Detection of Leptospira-specific antibodies using a recombinant antigen-based enzyme-linked immunosorbent assay. The American journal of tropical medicine and hygiene 2013. link 17 Shimabukuro FH, Costa VM, Silva RC, Langoni H, da Silva AV, de Carvalho LR et al.. Prozone effects in microscopic agglutination tests for leptospirosis in the sera of mice infected with the pathogenic Leptospira interrogans serovar Canicola. Memorias do Instituto Oswaldo Cruz 2013. link 18 Yan W, Saleem MH, McDonough P, McDonough SP, Divers TJ, Chang YF. Development of an enzyme-linked immunosorbent assay using a recombinant LigA fragment comprising repeat domains 4 to 7.5 as an antigen for diagnosis of equine leptospirosis. Clinical and vaccine immunology : CVI 2013. link 19 Tanganuchitcharnchai A, Smythe L, Dohnt M, Hartskeerl R, Vongsouvath M, Davong V et al.. Evaluation of the Standard Diagnostics Leptospira IgM ELISA for diagnosis of acute leptospirosis in Lao PDR. Transactions of the Royal Society of Tropical Medicine and Hygiene 2012. link 20 Lewis FI, Gunn GJ, McKendrick IJ, Murray FM. Bayesian inference for within-herd prevalence of Leptospira interrogans serovar Hardjo using bulk milk antibody testing. Biostatistics (Oxford, England) 2009. link 21 Lin X, Chen Y, Yan J. Recombinant multiepitope protein for diagnosis of leptospirosis. Clinical and vaccine immunology : CVI 2008. link 22 Oliveira TR, Longhi MT, de Morais ZM, Romero EC, Blanco RM, Kirchgatter K et al.. Evaluation of leptospiral recombinant antigens MPL17 and MPL21 for serological diagnosis of leptospirosis by enzyme-linked immunosorbent assays. Clinical and vaccine immunology : CVI 2008. link 23 Flannery B, Costa D, Carvalho FP, Guerreiro H, Matsunaga J, Da Silva ED et al.. Evaluation of recombinant Leptospira antigen-based enzyme-linked immunosorbent assays for the serodiagnosis of leptospirosis. Journal of clinical microbiology 2001. link 24 Brandão AP, Camargo ED, da Silva ED, Silva MV, Abrão RV. Macroscopic agglutination test for rapid diagnosis of human leptospirosis. Journal of clinical microbiology 1998. link 25 Surujballi O, Henning D, Marenger R, Howlett C. Development of a monoclonal antibody-based competitive enzyme-linked immunosorbent assay for the detection of Leptospira borgpetersenii serovar hardjo type hardjobovis antibodies in bovine sera. Canadian journal of veterinary research = Revue canadienne de recherche veterinaire 1997. link 26 Surujballi OP, Marenger RM, Eaglesome MD, Sugden EA. Development and initial evaluation of an indirect enzyme-linked immunosorbent assay for the detection of Leptospira interrogans serovar hardjo antibodies in bovine sera. Canadian journal of veterinary research = Revue canadienne de recherche veterinaire 1997. link 27 Midwinter A, Vinh T, Faine S, Adler B. Characterization of an antigenic oligosaccharide from Leptospira interrogans serovar pomona and its role in immunity. Infection and immunity 1994. link 28 Chapman AJ, Everard CO, Faine S, Adler B. Antigens recognized by the human immune response to severe leptospirosis in Barbados. Epidemiology and infection 1991. link 29 Masuzawa T, Nakamura R, Shimizu T, Iwamoto Y, Morita T, Yanagihara Y. Immunological characteristics of the glycolipid antigen of Leptospira interrogans serovar lai. Infection and immunity 1989. link 30 Milner AR, Jackson KB, Woodruff K, Smart IJ. Enzyme-linked immunosorbent assay for determining specific immunoglobulin M in infections caused by Leptospira interrogans serovar hardjo. Journal of clinical microbiology 1985. link 31 Cursons RT, Pyke PA. Diffusion in gel-enzyme-linked immunosorbent assay-a new serological test for leptospirosis. Journal of clinical pathology 1981. link 32 Pujato N, Gimenez JM, Peretti LE, Landolt NY, Jacob P, Chiani YT et al.. Development of a new accurate lateral flow immunoassay for diagnosis of human leptospirosis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2024. link 33 Blanco RM, Lima EDS, de Haro GN, Kamikawa CM, Blanco RM, Vincentini AP et al.. Comparative analysis of a novel N-butanol-prepared antigen vs thermo-resistant and sonicated antigens for human leptospirosis detection. Letters in applied microbiology 2024. link 34 Martínez ML, Rodríguez MA, Saraullo VR, Irazu LE, Hamer M, Watanabe O et al.. Comparison of ELISA using recombinant LipL32 and sonicated antigen of leptospira for detecting bovine leptospirosis. Acta tropica 2022. link 35 Padilha BCR, Simão HQ, Oliveira TL, Hartwig DD. The use of ErpY-like recombinant protein from Leptospira interrogans in the development of an immunodiagnostic test for swine leptospirosis. Acta tropica 2019. link 36 Gamage C, Sarathkumara Y, Weerakkodi V, Shiokawa K, Yoshimatsu K, Arikawa J. Development and evaluation of monoclonal antibody-based antigen capture enzyme-linked immunosorbent assay for the diagnosis of acute leptospirosis in humans. Journal of immunological methods 2018. link 37 Ijaz M, Abbas SN, Farooqi SH, Aqib AI, Anwar GA, Rehman A et al.. Sero-epidemiology and hemato-biochemical study of bovine leptospirosis in flood affected zone of Pakistan. Acta tropica 2018. link 38 Rosa MI, Reis MFD, Simon C, Dondossola E, Alexandre MC, Colonetti T et al.. IgM ELISA for leptospirosis diagnosis: a systematic review and meta-analysis. Ciencia & saude coletiva 2017. link 39 Chandy S, Kirubanandhan L, Hemavathy P, Khadeeja AM, Kurian SJ, Venkataraman K et al.. Serovar prevalence of Leptospira in semirural India and the development of an IgM-based indirect ELISA. Journal of infection in developing countries 2017. link 40 Penna B, Marassi CD, Libonati H, Narduche L, Lilenbaum W, Bourhy P. Diagnostic accuracy of an in-house ELISA using the intermediate species Leptospira fainei as antigen for diagnosis of acute leptospirosis in dogs. Comparative immunology, microbiology and infectious diseases 2017. link 41 Anita K, Premlatha MM, Kanagavel M, Akino Mercy CS, Raja V, Shanmughapriya S et al.. Evaluation of combined B cell specific N-terminal immunogenic domains of LipL21 for diagnosis of leptospirosis. International journal of biological macromolecules 2016. link 42 Schlichting D, Nöckler K, Bahn P, Luge E, Greiner M, Müller-Graf C et al.. Estimation of the sensitivity and specificity of a Leptospira spp. in-house ELISA through Bayesian modelling. International journal of medical microbiology : IJMM 2015. link 43 Nagalingam M, Thirumalesh SR, Kalleshamurthy T, Niharika N, Balamurugan V, Shome R et al.. Comparative evaluation of recombinant LigB protein and heat-killed antigen-based latex agglutination test with microscopic agglutination test for diagnosis of bovine leptospirosis. Tropical animal health and production 2015. link 44 Klaasen HL, van der Veen M, Molkenboer MJ, Bruderer U. Development of Leptospira in vitro potency assays: EU/industry experience and perspectives. Biologicals : journal of the International Association of Biological Standardization 2013. link 45 Cermakova Z, Kucerova P, Pliskova L, Kubickova P. Real-time PCR method for the detection of the gene encoding surface lipoprotein LipL32 of pathogenic Leptospira: use in the laboratory diagnosis of the acute form of leptospirosis. Scandinavian journal of infectious diseases 2013. link 46 Subathra M, Senthilkumar TM, Ramadass P. Recombinant OmpL1 protein as a diagnostic antigen for the detection of canine leptospirosis. Applied biochemistry and biotechnology 2013. link 47 Hartleben CP, Leal FM, Monte LG, Hartwig DD, Seixas FK, Vasconcellos SA et al.. Serological analysis by enzyme-linked immunosorbent assay using recombinant antigen LipL32 for the diagnosis of swine leptospirosis. Current microbiology 2013. link 48 Balassiano IT, Vital-Brazil JM, Pereira MM. Leptospirosis diagnosis by immunocapture polymerase chain reaction: a new tool for early diagnosis and epidemiologic surveillance. Diagnostic microbiology and infectious disease 2012. link 49 Habarta A, Abreu PA, Olivera N, Hauk P, Cédola MT, Ferrer MF et al.. Increased immunogenicity to LipL32 of Leptospira interrogans when expressed as a fusion protein with the cholera toxin B subunit. Current microbiology 2011. link 50 Dehnhard N, Poisbleau M, Demongin L, Chastel O, van Noordwijk HJ, Quillfeldt P. Leucocyte profiles and corticosterone in chicks of southern rockhopper penguins. Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology 2011. link 51 Subathra M, Senthilkumar TM, Ramadass P, Dhinakar Raj G. Development of rapid flow-through-based dot-immunoassay for serodiagnosis of leptospirosis in dogs. Comparative immunology, microbiology and infectious diseases 2011. link 52 Aviat F, Rochereau-Roulet S, Branger C, Estavoyer JM, Chatrenet B, Orsonneau JL et al.. Synthetic peptide issued from Hap1/LipL32 for new early serodiagnosis of human leptospirosis. Comparative immunology, microbiology and infectious diseases 2010. link 53 Lottersberger J, Guerrero SA, Tonarelli GG, Frank R, Tarabla H, Vanasco NB. Epitope mapping of pathogenic Leptospira LipL32. Letters in applied microbiology 2009. link 54 Natarajaseenivasan K, Vijayachari P, Sharma S, Sugunan AP, Selvin J, Sehgal SC. Serodiagnosis of severe leptospirosis: evaluation of ELISA based on the recombinant OmpL1 or LipL41 antigens of Leptospira interrogans serovar autumnalis. Annals of tropical medicine and parasitology 2008. link 55 Chirathaworn C, Kaewopas Y, Poovorawan Y, Suwancharoen D. Comparison of a slide agglutination test, LeptoTek Dri-Dot, and IgM-ELISA with microscopic agglutination test for Leptospira antibody detection. The Southeast Asian journal of tropical medicine and public health 2007. link 56 Neves FO, Abreu PA, Vasconcellos SA, de Morais ZM, Romero EC, Nascimento AL. Identification of a novel potential antigen for early-phase serodiagnosis of leptospirosis. Archives of microbiology 2007. link 57 Slack A, Symonds M, Dohnt M, Harris C, Brookes D, Smythe L. Evaluation of a modified Taqman assay detecting pathogenic Leptospira spp. against culture and Leptospira-specific IgM enzyme-linked immunosorbent assay in a clinical environment. Diagnostic microbiology and infectious disease 2007. link 58 Tahiliani P, Kumar MM, Chandu D, Kumar A, Nagaraj C, Nandi D. Gel purified LipL32: a prospective antigen for detection of leptospirosis. Journal of postgraduate medicine 2005. link 59 Bomfim MR, Ko A, Koury MC. Evaluation of the recombinant LipL32 in enzyme-linked immunosorbent assay for the serodiagnosis of bovine leptospirosis. Veterinary microbiology 2005. link 60 Nakarin J, Pradutkanchana S. Evaluation of enzyme-linked immunosorbent assay and indirect hemagglutination assay for detection of leptospiral antibody by using three different antigens. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2004. link 61 Dey S, Mohan CM, Kumar TM, Ramadass P, Nainar AM, Nachimuthu K. Recombinant LipL32 antigen-based single serum dilution ELISA for detection of canine leptospirosis. Veterinary microbiology 2004. link 62 Vanasco NB, Lottersberger J, Sequeira MD, Tarabla H. Development and validation of an ELISA for the detection of leptospire-specific antibodies in rodents. Veterinary microbiology 2001. link00394-7) 63 Park SH, Ahn BY, Kim MJ. Expression and immunologic characterization of recombinant heat shock protein 58 of Leptospira species: a major target antigen of the humoral immune response. DNA and cell biology 1999. link 64 da Silva MV, Nakamura PM, Camargo ED, Batista L, Vaz AJ, Romero EC et al.. Immunodiagnosis of human leptospirosis by dot-ELISA for the detection of IgM, IgG, and IgA antibodies. The American journal of tropical medicine and hygiene 1997. link 65 Ribeiro MA, Brandão AP, Romero EC. Evaluation of diagnostic tests for human leptospirosis. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 1996. link 66 Masuzawa T, Suzuki R, Yanagihara Y. Protective activity of rabbit polyclonal anti-idiotype antibody against Leptospira interrogans infection in hamsters. Biological & pharmaceutical bulletin 1996. link 67 Silva MV, Camargo ED, Batista L, Vaz AJ, Brandão AP, Nakamura PM et al.. Behaviour of specific IgM, IgG and IgA class antibodies in human leptospirosis during the acute phase of the disease and during convalescence. The Journal of tropical medicine and hygiene 1995. link 68 Sting R, Dura U. Isolation of serovar-specific leptospiral antigens for use in an enzyme-linked immunosorbent assay (ELISA) compared with the microscopic agglutination test and immunofluorescence. Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B 1994. link 69 da Silva MV, Nakamura PM, Camargo ED, Batista L, Vaz AJ, Brandão AP et al.. Dot-ELISA-IgM in saliva for the diagnosis of human leptospirosis using polyester fabric-resin as support (preliminary report). Revista do Instituto de Medicina Tropical de Sao Paulo 1994. link 70 Sugiyama Y, Sugiyama F, Yagami K. Comparative study on cross-reaction of leptospiral antibodies in several serological tests to detect antibodies to Borrelia burgdorferi in dogs. The Journal of veterinary medical science 1993. link 71 Ribeiro MA, Sakata EE, Silva MV, Camargo ED, Vaz AJ, De Brito T. Antigens involved in the human antibody response to natural infections with Leptospira interrogans serovar copenhageni. The Journal of tropical medicine and hygiene 1992. link 72 da Silva MV, Dias Camargo E, Vaz AJ, Batista L. Immunodiagnosis of human leptospirosis using saliva. Transactions of the Royal Society of Tropical Medicine and Hygiene 1992. link90113-q) 73 Cinco M, Balanzin D, Banfi E. Evaluation of an immunoenzymatic test (ELISA) for the diagnosis of leptospirosis in Italy. European journal of epidemiology 1992. link 74 Petchclai B, Hiranras S, Potha U. Gold immunoblot analysis of IgM-specific antibody in the diagnosis of human leptospirosis. The American journal of tropical medicine and hygiene 1991. link 75 Staak C, Mekaprateep M, Kämpe U, Schönberg A. Serological reactions of leptospirosis-positive (MAR and CFT) bovine sera in ELISA. Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B 1990. link 76 Segers RP, De Nijs A, van Kooten PJ, Gaastra W, van der Zeijst BA. The use of immunodeficient male (CBA/N x BALB/c) F1 mice to produce monoclonal antibodies directed to proteins of Leptospira interrogans rather than to immunodominant lipopolysaccharides. Hybridoma 1990. link 77 Chapman AJ, Adler B, Faine S. Antigens recognised by the human immune response to infection with Leptospira interrogans serovar hardjo. Journal of medical microbiology 1988. link 78 Takimoto T, Ono E, Ito T, Yanagawa R. Affinity constants of anti-leptospira monoclonal antibodies, numbers of antigenic determinants on leptospiras, and their influence on the microscopic agglutination test and ELISA. Microbiology and immunology 1988. link 79 Alves VA, Vianna MR, Yasuda PH, De Brito T. Detection of leptospiral antigen in the human liver and kidney using an immunoperoxidase staining procedure. The Journal of pathology 1987. link 80 Chapman AJ, Adler B, Faine S. Genus-specific antigens in Leptospira revealed by immunoblotting. Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology 1987. link80046-9) 81 Hartman EG, van den Ingh TS, Rothuizen J. Clinical, pathological and serological features of spontaneous canine leptospirosis. An evaluation of the IgM- and IgG-specific ELISA. Veterinary immunology and immunopathology 1986. link90078-4) 82 Cousins DV, Robertson GM. Use of enzyme immunoassay in a serological survey of leptospirosis in sheep. Australian veterinary journal 1986. link 83 Yasuda PH, Hoshino-Shimizu S, Yamashiro EH, De Brito T. Experimental leptospirosis (L. interrogans serovar icterohaemorrhagiae) of the guinea pig: leptospiral antigen, gamma globulin and complement C3 detection in the kidney. Experimental pathology 1986. link80004-4) 84 Terpstra WJ, Korver H, van Leeuwen J, Klatser PR, Kolk AH. The classification of Sejroe group serovars of Leptospira interrogans with monoclonal antibodies. Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology 1985. link80082-1) 85 Fairbrother JM. Antibody response to genus- and serovar-specific leptospiral antigens in Leptospira-infected cows. American journal of veterinary research 1985. link 86 Thiermann AB. Isolation of leptospires in diagnosis of leptospirosis. Modern veterinary practice 1984. link 87 Hartman EG, van Houten M, van der Donk JA, Frik JF. Determination of specific anti-leptospiral immunoglobulins M and G in sera of experimentally infected dogs by solid-phase enzyme-linked immunosorbent assay. Veterinary immunology and immunopathology 1984. link90026-6) 88 Ono E, Naiki M, Yanagawa R. Isolation of an antigenic oligosaccharide fraction from Leptospira interrogans serovar canicola with a monoclonal antibody. Journal of general microbiology 1984. link 89 Nardiello S, Pizzella T, Russo M, Galanti B. ELISA determination of IgM anti-LPS in the early phase of typhoid fever. Bollettino dell'Istituto sieroterapico milanese 1983. link 90 Terpstra WJ, Jabboury-Postema J, Korver H. Immunoperoxidase staining of leptospires in blood and urine. Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious... 1983. link 91 Ellis TM, Robertson GM, Hustas L, Kirby M. Detection of leptospires in tissue using an immunoperoxidase staining procedure. Australian veterinary journal 1983. link 92 Adler B, Cousins DV, Faine S, Robertson GM. Bovine IgM and IgG response to Leptospira interrogans serovar hardjo as measured by enzyme immunoassay. Veterinary microbiology 1982. link90050-5) 93 Adler B, Faine S, Gordon LM. The enzyme-linked immunosorbent assay (ELISA) as a serological test for detecting antibodies against Leptospira interrogans serovar hardjo in sheep. Australian veterinary journal 1981. link 94 Roch P, Srámková L, Salák J. The agglutinating and immunofluorescent activities of antileptospiral antibodies of human sera and of immunoglobulins M and G. Journal of hygiene, epidemiology, microbiology, and immunology 1976. link